Clinical Trial Update: Immunogenicity and Safety of GBS-NN/NN2 in Pregnant Women [Phase 2]

View source ↗

Summary

A Phase 2 study in pregnant women evaluated the immunogenicity and safety of the GBS-NN/NN2 vaccine with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Group Streptococcal Infection

Drugs mentioned

• GBS-NN/NN2 (GBS-NN/NN2)

Snippet

Sponsor: Minervax ApS | Conditions: Group B Streptococcal Infection | Phase 2 | Status: COMPLETED | Results posted: 2025-01-13